Latest Conference Coverage


Sarah Wilson, PhD: The Burden of Normality Post-Epilepsy Surgery

Sarah Wilson, PhD: The Burden of Normality Post-Epilepsy Surgery

August 2nd 2019

The clinical neuropsychologist and head of the School of Psychological Sciences at the University of Melbourne spoke about what physicians need to provide to help patients through the adjustment period after epilepsy surgery.


Sarah Wilson, PhD: The Promise of Neurorehabilitation After Epilepsy Surgery

Sarah Wilson, PhD: The Promise of Neurorehabilitation After Epilepsy Surgery

August 1st 2019

The clinical neuropsychologist and head of the School of Psychological Sciences at the University of Melbourne discussed the early-stage research into neurorehabilitation post-epilepsy surgery, and the promise it might hold to address surgery’s long-term risks.


Alon Ironi: Introducing Nerivio Migra in Migraine Care

Alon Ironi: Introducing Nerivio Migra in Migraine Care

August 1st 2019

After its recent FDA clearance, the smartphone-controlled Nerivio Migra makes its entrance into the market in the fall. Theranica’s CEO and co-founder spoke to its clinical efficacy and advantages for patients and physicians.


Michael Sperling, MD: Noninvasive Techniques in Epilepsy

Michael Sperling, MD: Noninvasive Techniques in Epilepsy

July 31st 2019

The director of the Jefferson Comprehensive Epilepsy Center discussed what’s currently being developed in the treatment of epilepsy, as well as the emergence of different methods of stimulation and neuromodulation.


sTMS Proves Safe, Effective for Migraine With Medication Overuse

sTMS Proves Safe, Effective for Migraine With Medication Overuse

July 30th 2019

The use of single-pulse transcranial magnetic stimulation, while already FDA-approved for acute and preventive migraine treatment, has shown that it can be effective in reducing the need for acute headache medications in patients with migraine.


Dawn Buse, PhD: Inappropriate Prescriptions in Acute, Preventive Migraine Treatment

Dawn Buse, PhD: Inappropriate Prescriptions in Acute, Preventive Migraine Treatment

July 30th 2019

The clinical professor of neurology at Albert Einstein College of Medicine spoke to the findings of the OVERCOME study, and how recent literature has suggested that improper prescriptions and medication use in migraine have been ongoing in spite of the current recommendations.


David Wolk, MD: Utilizing MRI in Alzheimer Disease

David Wolk, MD: Utilizing MRI in Alzheimer Disease

July 29th 2019

The co-director of the University of Pennsylvania Memory Center will share additional insights on Alzheimer disease at the upcoming International Congress on the Future of Neurology, taking place September 27-28, 2019 in New York City.


Jessica Ailani, MD: Overcoming Barriers and Closing Gaps in Migraine

Jessica Ailani, MD: Overcoming Barriers and Closing Gaps in Migraine

July 29th 2019

The director of the MedStar Georgetown Headache Center discussed the barriers to patient and clinician education in migraine and the gap in available interventions for the diverse patient population.


Jeffrey L. Cummings, MD, ScD: Addressing Agitation, Psychosis in Alzheimer Disease

Jeffrey L. Cummings, MD, ScD: Addressing Agitation, Psychosis in Alzheimer Disease

July 28th 2019

The director emeritus of the Cleveland Clinic Lou Ruvo Center for Brain Health and vice chair of the department of brain health at the University of Nevada Las Vegas spoke about therapies under investigation for the treatment of agitation and psychosis in Alzheimer disease.


James W. Wheless, MD: Making Treatment Decisions in Epilepsy

James W. Wheless, MD: Making Treatment Decisions in Epilepsy

July 26th 2019

The professor and chief of pediatric neurology at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center discussed the decision-making process for choosing interventions for patients with epilepsy, and how to keep patients adherent.


Anthony Fiorino, MD, PhD: Using nVNS in Various Migraine Populations

Anthony Fiorino, MD, PhD: Using nVNS in Various Migraine Populations

July 25th 2019

The chief medical officer of electroCore discussed the various data which have been published on the use of noninvasive vagus nerve stimulation in different populations of patients with migraine and headache.


Christopher Gottschalk, MD: Long-Term Safety in Preventive Migraine Therapies

Christopher Gottschalk, MD: Long-Term Safety in Preventive Migraine Therapies

July 25th 2019

The director of headache medicine and chief of general neurology at Yale Medicine discussed the long-term success the new preventive migraine therapies have shown thus far, and how the lack of safety concerns will improve how they’re utilized.


David Llewellyn, PhD: The Impact of Lifestyle Factors on Genetic Risk in Dementia

David Llewellyn, PhD: The Impact of Lifestyle Factors on Genetic Risk in Dementia

July 25th 2019

The associate professor of neuroepidemiology and digital health spoke about the importance of findings from an observational study which showed that adherence to a healthy lifestyle can offset the genetic risk for dementia.


Dawn Buse, PhD: Patient Referrals From Primary Care for Migraine

Dawn Buse, PhD: Patient Referrals From Primary Care for Migraine

July 24th 2019

The clinical professor of neurology at Albert Einstein College of Medicine discussed the referral process for patients with migraine and which patients may be too complex for the limited time primary care physicians have.


Highlights From the 2019 American Headache Society Annual Scientific Meeting

Highlights From the 2019 American Headache Society Annual Scientific Meeting

July 24th 2019

This week’s edition features highlights from NeurologyLive’s coverage of the American Headache Society’s annual scientific meeting.


Deborah Friedman, MD, MPH: Coordinating Care in Telemedicine

Deborah Friedman, MD, MPH: Coordinating Care in Telemedicine

July 23rd 2019

The professor of neurology, neurotherapeutics, and ophthalmology at UT Southwestern discussed the need to better coordinate care between providers when telemedicine is being utilized in headache and migraine care.


James W. Wheless, MD: The Consequences of Uncontrolled Epilepsy

James W. Wheless, MD: The Consequences of Uncontrolled Epilepsy

July 22nd 2019

The professor and chief of pediatric neurology at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center spoke about the concerns of uncontrolled epilepsy and how to determine if a patient requires more than one treatment for their epilepsy.


Ubrogepant's Potential in the Migraine Treatment Landscape

Ubrogepant's Potential in the Migraine Treatment Landscape

July 21st 2019

The director of the Headache Center of Southern California shared insight into the success of ubrogepant in patients who failed on triptans, and how the future of migraine treatment may need to focus on combination approaches.


Kelly Knupp, MD: Increasing Patient Curiosity About CBD in Epilepsy

Kelly Knupp, MD: Increasing Patient Curiosity About CBD in Epilepsy

July 19th 2019

The pediatric neurologist and epilepsy specialist at Children’s Hospital Colorado discussed the popularity of cannabidiol from coverage in the media, and how she sees its use—and the understanding of it—evolving in the coming years.


Researchers Continue to Make In-Roads Towards Infectious Link to Alzheimer Disease

Researchers Continue to Make In-Roads Towards Infectious Link to Alzheimer Disease

July 19th 2019

The topic was the focus of a lively panel discussion and several posters at the 2019 Alzheimer’s Association International Conference, where experts in the field debated on the validity of current findings and theories.


Jonathan Voglein, MD: Epilepsy in Alzheimer Disease

Jonathan Voglein, MD: Epilepsy in Alzheimer Disease

July 19th 2019

This data demonstrates that patients with Alzheimer disease are at an increased risk for seizures, in particular in more advanced disease stages, which emphasizes a need for seizure history assessment to inform individual therapeutic decisions and the necessity of systematic treatment studies.


Blood-Based Biomarkers Promising for Predicting Alzheimer Disease

Blood-Based Biomarkers Promising for Predicting Alzheimer Disease

July 18th 2019

Previous research demonstrated that plasma neuronal-enriched extracellular vesicles exhibited elevated levels of p-tau, amyloid-beta 42, and phosphorylated insulin receptor substrate.


Jessica Ailani, MD: Lowering the Opioid Use Rates in Migraine

Jessica Ailani, MD: Lowering the Opioid Use Rates in Migraine

July 18th 2019

The director of the MedStar Georgetown Headache Center spoke about the higher-than-desired rates of opioid prescriptions for patients with migraine, and how new treatment options and provider education can help lower those numbers.


Improving Alzheimer Care in the Emergency Department: Q&A With Manish Shah, MD, MPH

Improving Alzheimer Care in the Emergency Department: Q&A With Manish Shah, MD, MPH

July 18th 2019

The professor of emergency medicine at the University of Wisconsin-Madison School of Medicine and Public Health spoke about the challenges physicians face in the emergency department when dealing with patients that are cognitively impaired.


Exercise May Protect Against Cognitive Decline in Adults With Elevated Amyloid-Beta

Exercise May Protect Against Cognitive Decline in Adults With Elevated Amyloid-Beta

July 18th 2019

In addition to physical activity, lower vascular risk factors, assessed via the Framingham risk score, were independently associated with slower PACC decline and gray matter volume loss.


Clive Ballard, MD: The State of Nursing Home Care in Dementia

Clive Ballard, MD: The State of Nursing Home Care in Dementia

July 17th 2019

The professor of age-related diseases and Dean of the University of Exeter Medical School spoke about the need for proper training of nursing home staff in order to improve quality of life in patients with dementia.


Susan Hutchinson, MD: The Potential of the Gepant Class in Acute Migraine

Susan Hutchinson, MD: The Potential of the Gepant Class in Acute Migraine

July 17th 2019

The director of the Orange County Migraine and Headache Center spoke about the adherence issues in acute migraine treatment and how the safety profile of investigational medications such as rimegepant and ubrogepant suggests they may be able to address them.


Jeffery Vance, MD, PhD: Role of Genetics in Distinguishing Alzheimer Risk

Jeffery Vance, MD, PhD: Role of Genetics in Distinguishing Alzheimer Risk

July 17th 2019

The professor of neurology and founding chair of the John T. Macdonald Foundation Department of Human Genetics at the University of Miami spoke about how the risk of Alzheimer disease differs between ethnic groups, despite being associated with the same genetic marker.


Using a Precision-Medicine Platform to Address Polypharmacy in Cognitive Impairment

Using a Precision-Medicine Platform to Address Polypharmacy in Cognitive Impairment

July 17th 2019

uMETHOD Health has implemented a precision-medicine platform to create personalized, multidomain care plans for the treatment of dementia and mild Alzheimer disease.

© 2024 MJH Life Sciences

All rights reserved.